Pascal David Johann
University of Augsburg · 198 works · 10,833 citations · h-index 37
Top works
- Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups
- New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
- The landscape of genomic alterations across childhood cancers
- Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas
- Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
- Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
- Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes
- Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma
- Sarcoma classification by DNA methylation profiling
- Active medulloblastoma enhancers reveal subgroup-specific cellular origins
- The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets
- Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults
- Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus
- Papillary Tumor of the Pineal Region: A Distinct Molecular Entity
- Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors
- Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis
- ATYPICAL TERATOID RHABDOID TUMOUR
- Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumors
- Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor
- Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1‐deficient non‐rhabdoid tumor with favorable long‐term outcome